Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,017 followers.

New article: Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor https://t.co/dk9waJvwnu #MMSM #MultipleMyeloma #hematology https://t.co/AJavJaQPkb

Reply Repost Favourite

Treating relapsed and refractory multiple myeloma | CPAA https://t.co/GN8kJy1WN6

Reply Repost Favourite